PharmaTelevision offers biopharma companies opportunity to reach key decision makers in financial sector

PharmaTelevision today announced that it is offering pharma and biotech companies the opportunity to reach key decision makers in the financial sector.

To celebrate their new relationship with Reuters Insider, PharmaTelevision(R) is offering companies an opportunity to film, host and promote their financial or corporate messages between 21-25 June 2010.

Dr Fintan Walton, Chairman of PharmaTelevision, said "When you are looking to raise funding, communication is the key to winning the deal and building your business. Our clients benefit from our targeted approach, identifying the key decision makers from a resource of over 500,000 prospects through Reuters Insider. PharmaTelevision's Financial Report helps companies communicate their financial or corporate message - with impact."

Anne Vindenes Allen, Managing Director of PharmaTelevision, said "Our team of television professionals help companies create top quality productions that combine video, text and advanced web features. Add to this PharmaTelevision's power of distribution to top decision makers, and our ability to syndicate videos to other target audiences, and you have a formulae to help our industry progress. That's why more companies are now choosing PharmaTelevision to convey their message."

Source:

PharmaTelevision Ltd

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.